ArticlePharmaceutics2025

DOPC Liposomal Formulation of Antimicrobial Peptide LL17-32 with Reduced Cytotoxicity: A Promising Carrier Against

Jinyang Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.